Skip to main content
Clinical Trials/NCT00580476
NCT00580476
Active, not recruiting
Not Applicable

Assessing Depression in a Geriatric Cancer Population

Memorial Sloan Kettering Cancer Center1 site in 1 country201 target enrollmentSeptember 2006

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Breast Cancer
Sponsor
Memorial Sloan Kettering Cancer Center
Enrollment
201
Locations
1
Primary Endpoint
Test the sensitivity and specificity of the Geriatric Depression Scale-Short Form and two other widely used assessments of depression to detect major and minor depression in a geriatric breast and prostate cancer population.
Status
Active, not recruiting
Last Updated
2 years ago

Overview

Brief Summary

The goal of this study is to learn more about how we measure depression in elderly cancer patients (patients aged 70 and older). Depression is one of the most common causes of emotional distress in the elderly and continues to be under-recognized. This is a problem because depression can have a negative impact on quality of life. The symptoms of depression are linked to poor health outcomes and higher costs of health care. In fact, depression is one of the top five concerns facing the elderly today.

Detailed Description

We have a few questionnaires that have been used to measure depression, but we do not know how these measures work with people with cancer. This study will help us answer this question. To complete this study, we need people who may or may not be feeling down or depressed. If you choose to take part, you will be asked to do the following: 1. Fill out questionnaires that ask about: * Your age, eduction, race, and income * Your mood In all, these questionnaires will take about 10 minutes to complete. 2. Answer questions about your mood. This will also take about 10 minutes to complete.

Registry
clinicaltrials.gov
Start Date
September 2006
End Date
June 10, 2025
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Age 70 and older
  • Diagnosis of early or late stage prostate cancer, or diagnosis of early or late stage breast cancer
  • Actively engaged in one of the following cancer treatments: chemotherapy, radiation therapy, hormone therapy
  • Able to provide informed consent
  • Ability to converse, write and read English

Exclusion Criteria

  • 1.Major psychopathology or cognitive impairment likely in the judgment of the research staff to interfere with the participation or completion of the protocol.

Outcomes

Primary Outcomes

Test the sensitivity and specificity of the Geriatric Depression Scale-Short Form and two other widely used assessments of depression to detect major and minor depression in a geriatric breast and prostate cancer population.

Time Frame: 2 years

Secondary Outcomes

  • To develop a cut-off score for the GDS that is specific to a cancer population.(2 years)

Study Sites (1)

Loading locations...

Similar Trials